More
    HomeEcosystem NewsLatest FundingAngel Investors Back Egyptian Healthtech Startup 30Med to Transform Medical Learning

    Angel Investors Back Egyptian Healthtech Startup 30Med to Transform Medical Learning

    Published on

    spot_img

    Egyptian healthtech startup 30Med has announced securing pre-seed funding from undisclosed angel investors, marking a significant milestone in its journey to revolutionize medical education. The funding round is expected to provide 30Med with the necessary resources to enhance its platform and broaden its reach within the medical community.

    Founded in 2023 by Ayman Ragab, 30Med operates in the business-to-business (B2B) space, with a primary objective of bridging the gap between pharmaceutical companies and physicians. The startup has gained recognition for its innovative approach, leveraging interactive videos and conference events to showcase new medicines and facilitate continuous learning for medical professionals.

    With a user base exceeding 2,000 actively engaged doctors, 30Med has established itself as a prominent player in the field, offering a platform for physicians to stay updated on the latest advancements in medicine and pharmaceuticals. Dr. Ayman Ragab, CEO of 30Med, expressed enthusiasm about the funding, stating, “This funding is a strong validation of our mission. It allows us to accelerate our efforts in transforming medical education.”

    30Med’s success can be attributed to its strategic partnerships with pharmaceutical companies in Egypt. These partnerships underscore the startup’s commitment to reshaping the medical education landscape within the country. By facilitating collaboration between healthcare providers and pharmaceutical firms, 30Med aims to drive innovation and improve patient care standards.

    The pre-seed funding represents a vote of confidence from investors in 30Med’s vision and potential impact on the healthcare sector. As the startup continues to evolve and expand its offerings, it is poised to play a significant role in shaping the future of medical education in Egypt and beyond.

    Latest articles

    “We Once Missed a 10x Exit Opportunity” — Ex-Zoona CEO Reflects One Year After Chipper Cash Deal

    "Having clarity on exits and stakeholders’ ambitions is critical as you scale.”

    Cauris Finance Lands $40M to Fund Africa’s Fintech Ecosystem

    In 2023, the firm participated in a $13 million pre-Series A funding round for Ghanaian e-logistics startup Jetstream Africa, blending equity and debt to drive growth.

    Big Promises, Short Lives: The Lifecycle Problem of African Corporate Venture Capital

    The recent closure of ARM Labs Lagos Techstars Accelerator is not an isolated case.

    Khulisani Ventures’ $16.5M Fund Targets High-Growth Startups in South Africa — Applications Close January 2025

    The program seeks businesses generating annual revenues of R5–R8 million, with positive cash flows and strong financial reporting.

    More like this

    “We Once Missed a 10x Exit Opportunity” — Ex-Zoona CEO Reflects One Year After Chipper Cash Deal

    "Having clarity on exits and stakeholders’ ambitions is critical as you scale.”

    Cauris Finance Lands $40M to Fund Africa’s Fintech Ecosystem

    In 2023, the firm participated in a $13 million pre-Series A funding round for Ghanaian e-logistics startup Jetstream Africa, blending equity and debt to drive growth.

    Big Promises, Short Lives: The Lifecycle Problem of African Corporate Venture Capital

    The recent closure of ARM Labs Lagos Techstars Accelerator is not an isolated case.